Sponsors & Partners

Com-COV

This study is being led by the Oxford Vaccine Group at the University of Oxford, and delivered by a network of trial sites across the UK.

The study is funded by the Vaccine Task Force and the National Institute for Health Research (NIHR).

Public Health England / UK Health Security Agency  are providing laboratory and statistical analysis support as NISEC collaborators.

Com-COV2

This study is being led by the Oxford Vaccine Group at the University of Oxford, and delivered by a network of trial sites across the UK.

The study is funded by the Vaccine Task Force, National Institute for Health Research (NIHR) and Collaboration for Epidemic Preparedness Innovations (CEPI)

Public Health England / UK Health Security Agency  are providing laboratory and statistical analysis support as NISEC collaborators. Novavax are supplying their COVID-19 vaccine for inclusion in the study.

Com-COV3

This study is being led by the Oxford Vaccine Group at the University of Oxford, and delivered by a network of trial sites across the UK.

The study is funded by the Vaccine Task Force, National Institute for Health Research (NIHR) and Collaboration for Epidemic Preparedness Innovations (CEPI)

Public Health England / UK Health Security Agency are providing laboratory and statistical analysis support as NISEC collaborators. Novavax are supplying their COVID-19 vaccine for inclusion in the study.